NEI Podcast Neuroscience Education Institute

What is avoidant/restrictive food intake disorder or ARFID? How does it differ from other disorders? How are intestinal microbiota involved when it comes to eating disorders?
Dr. Cynthia Bulik is a Distinguished Professor of Eating Disorders and Founding Director of the University of North Carolina (UNC) Center of Excellence for Eating Disorders and Professor of Nutrition, Gillings School of Global Public Health; and Associate Director, UNC Center for Psychiatric Genomics.
Dr. Bulik’s research teams at UNC (Center of Excellence for Eating Disorders-CEED) and Karolinska Institute (Centre for Eating Disorders Innovation-CEDI) are dedicated to deepening our understanding of the underlying biology and genetics of eating disorders and to advancing the evidence base for the treatment of these illnesses. As founder and co-chair of the Eating Disorders Working Group of the Psychiatric Genomics Consortium (PGC-ED), she leads the global effort to identify actionable genomic variation in eating disorders. She is Principal Investigator of the global Eating Disorders Genetics Initiative funded by the National Institute of Mental Health. She is also the Principal Investigator of the largest study of genetic and environmental contributors to avoidant/restrictive food intake disorder (ARFID-GEN), also funded by the National Institute of Mental Health. Together with Ian Carroll, PhD she conducts population-level and intensive longitudinal clinical investigations of the intestinal microbiota in eating disorders. For the past decade, with Donald Baucom, PhD and Jennifer Kirby, PhD she has developed and disseminated a suite of couple-based interventions for anorexia nervosa, bulimia nervosa, and binge-eating disorder (UNITE: UNiting couples In the Treatment of Eating disorders). She also serves as senior faculty on the SAMHSA-funded National Center of Excellence for Eating Disorders (NCEED)—the national authoritative source for information and training in eating disorders. She is dedicated to mentorship of junior investigators, especially women in STEM fields and is passionate about translating science for the public.

What has research demonstrated about the advantages and consequences of telehealth for the treatment of ADHD and mental health? How can we fill the gaps in underserved communities when it comes to telehealth treatment for ADHD?
With this special series, brought to you by the NEI Podcast we will address a different theme in psychopharmacology every 3 months. Each theme is split into 3 parts, with one part released each month. This theme is on novel perspectives and novel treatment approaches for Attention Deficit Hyperactivity Disorder (ADHD).
Today, Dr. Andy Cutler interviews Dr. Greg Mattingly on best practices and guidelines for using telemedicine for the treatment and management of ADHD.
Let’s listen in to Part 2 of our theme: The Challenges of Treating ADHD Online
Subscribe to the NEI Podcast, so that you don’t miss another episode!

What are common comorbidities with ASD and how difficult is it to differentiate these conditions from overlapping symptoms of ASD? What guidelines are there for managing agitation in autism spectrum disorder?
Robyn Thom, MD, is a child, adolescent, and adult psychiatrist at the Massachusetts General Hospital (MGH) Lurie Center for Autism and co-Director of the MGH Williams Syndrome Program. She is also an Assistant Professor of Psychiatry at Harvard Medical School. She specializes in diagnosing and treating comorbid psychiatric conditions in individuals with autism spectrum disorder and other developmental disabilities including Williams syndrome. Dr. Thom's research interests include psychopharmacology, anxiety disorders, Williams syndrome, medical comorbidity in adults with autism spectrum disorder, and brain aging.

What is the proposed neurocircuitry that underlies attention deficit hyperactivity disorder, or ADHD? What is known about the role of serotonin in ADHD? Particularly the 5HT2C and 5HT7 receptors?
With this special series, brought to you by the NEI Podcast, we will address a different theme in psychopharmacology every 3 months. Each theme is split into 3 parts, with one part released each month. This theme is on novel perspectives and novel treatment approaches for Attention Deficit Hyperactivity Disorder (ADHD).
Today, Dr. Andy Cutler interviews Dr. Stephen Stahl on the current state of ADHD and where the future lies.
Let’s listen in to Part 1 of our theme: Shifting Focus: A Novel Perspective on Attention Deficit Hyperactivity Disorder (ADHD)
Subscribe to the NEI Podcast, so that you don’t miss another episode!

In this episode, Dr. Jonathan Meyer addresses your unanswered questions from his presentation: Dopamine Partial Agonists: How They Work and Why They Don’t Always Play Nice with Other Antipsychotics.

In this episode, Dr. Jade Wu addresses your unanswered questions from her presentation: Goodnight Mom: Sleep Issues During Pregnancy and Postpartum.